IP Review

This publication includes IP covered under the following statements.

The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved. https://ucum.org/trac/wiki/TermsOfUse
Show Usage
- Unified Code for Units of Measure (UCUM) : ApplQtyUnit , Bundle/bun-1 ... Show 17 more
These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright © 2011 by the National Electrical Manufacturers Association.
Show Usage
- DICOM Controlled Terminology Definitions : AcquisitionModality , Bundle/bun-1 ... Show 6 more
This material contains content from LOINC . LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license . LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
Show Usage
- LOINC : Bundle/bun-1 , Bundle/bun-3 ... Show 34 more
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org .
Show Usage
- SNOMED Clinical Terms® (SNOMED CT®) : ApplQtyUnit , Bundle/bun-1 ... Show 30 more
This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Show Usage
World Health Organization (WHO)
Show Usage
衛生福利部中央健康保險署
Show Usage
衛生福利部資訊處
Show Usage
- 臺灣衛福部資訊處照護計畫類別 : Bundle/bun-imm , CarePlan/careplan-min and CarePlanTWPAS
- 臺灣衛福部資訊處識別碼類型 : Bundle/bun-1 , Bundle/bun-3 ... Show 4 more
衛生福利部食品藥物管理署
Show Usage
- 臺灣食藥署醫療器材許可證 : MedicationRequestTreatTWPAS and NHIMedicationFDA
- 臺灣食藥署藥品許可證 : MedicationRequestTreatTWPAS and NHIMedicationFDA

tw.gov.mohw.nhi.pas: 臺灣健保事前審查實作指引 ®© 衛生福利部中央健康保險署 | CC0 ( src )

(diagnosis.diagnosis.ofType(CodeableConcept).coding.where(code.matches('^(C)')).exists()).not() ( src )

ANTREX (R) 15MG TABLETS ( src )

APRESOLINE (R) S.C. TABLETS 25MG (HYDRALAZINE) ( src )

BUSULFEX (R) INJECTION ( src )

CAFERGOT TABLETS (R) ( src )

CARIN Consumer Directed Payer Data Exchange (CARIN IG for Blue Button®) ( src )

CARIN Consumer Directed Payer Data Exchange (CARIN IG for Blue Button®) (built Mon, Nov 28, 2022 15:15+0000+00:00) ( src )

CEPHANMYCIN (R) CAPSULES 500MG (CEPHALEXIN) ( src )

CLENIDERM (R) CREAM ( src )

COBAMETIN CAPSULES 250 (R) ( src )

DEFENSE (R) INJECTION 150MG/ML (CIMETIDINE) ( src )

DENDRID (R) STERILE OPHTHALMIC SOLUTION ( src )

DIPYRIDAN (R) SUGAR-COATED TABLETS ( src )

EMTHEXATE (R) 1000MG ( src )

ESIDRI S.C. TABLETS (R) ( src )

ESIDRI S.C. TABLETS (R)(鋁箔/膠箔) ( src )

EURAX (R) CREAM 10％ (CROTAMITON) ( src )

EURAX (R) LOTION 10％ "SWPH." (CROTAMITON) ( src )

FAKTU (R) OINTMENT ( src )

FLUATON(R) EYE OINTMENT ( src )

FLUENCY (R) CAPSULES ( src )

FORISTAL (R) TABLETS 1MG (DIMETHINDENE) ( src )

HEALON (R) ( src )

HOREMAN (R) TABLETS 150MG (XANTHINOL NICOTINATE) ( src )

HYDERGINE (R) AMPOULES 0.3MG/1ML ( src )

INSULIN ACTRAPID (R) 100I.U./ML INJECTION ( src )

ISMELIN (R) TABLETS 10MG (GUANETHIDINE SULFATE) ( src )

LOCASALEN OINTMENT (R) ( src )

Lendormin (R) 0.25mg Tablets ( src )

Letampin (R) F.C. Tablets 250mg ( src )

MELLERIL (R) 200MG RETARD TABLETS ( src )

METHERGIN (R) AMPOULES 0.2MG/1ML ( src )

METHERGIN (R) SUGER-COATED TABLETS ( src )

MYDRIACYL 0.5 ％ OPHTHALMIC SOLUTION (R) ( src )

Mobic (R) Tablets 15mg ( src )

Mobic (R) Tablets 7.5mg ( src )

NIFEREX(R) PN TABLETS ( src )

NOSPAN (R) TABLETS 30MG (DEXTROMETHORPHAN) ( src )

Nobelin (R) XR F.C. Tablets 500mg ( src )

PEDIALYTE (R) ORAL ELECTROLYTE (MAINTENANCE SOLUTION) ( src )

PIREHEXAL (R) FOR INJECTION ( src )

PORO (R) SOLUTION 24MG/ML (ACETAMINOPHEN) ( src )

PURSENNID 12MG S.C. TABLETS (R) ( src )

RIMACTANE (R) CAPSULES 150MG (RIFAMPICIN) ( src )

RIMACTANE (R) CAPSULES 300MG (RIFAMPICINE) ( src )

RxNorm為美國Unified Medical Language System®中的藥品代碼，取得UMLS®授權即可免費使用，可依情境選用此代碼。 ( src )

RxNorm為美國Unified Medical Language System®中的藥品代碼，取得UMLS®授權即可免費使用，可依情境選用此代碼。Code defined by a terminology system ( src )

SILVADENE CREAM (R) ( src )

SYNOPHYLATE(R)-GG TABLETS ( src )

SYNTOCINON 10 IU/1ML AMPOULES (R) ( src )

TADEX (R) 20MG TABLETS (TAMOXIFEN 20MG TABLETS) ( src )

TAVEGYL (R) AMPOULES ( src )

TETANUS IMMUNE GLOBULIN (HUMAN) U.S.P. 250 UNITS "HYPER-TET (R)" ( src )

THEOCLEAR (R) L.A.-130 CENULES (R) ( src )

THEOCLEAR(R) L.A.-260 CENULES(R) ( src )

TOGAMYCIN (R) INJECTION 2GM (SPECTINOMYCIN HYDROCHLORIDE) ( src )

TOPSYM (R) EMOLLIENT 0.5MG/GM (FLUOCINONIDE) ( src )

TORECAN SUGAR-COATED TABLETS 6.5MG (R) ( src )

TYROSUR(R) NASAL OINTMENT ( src )

There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose. For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine® (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting". In these cases, two medication requests would be created that could be grouped together. The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. ( src )

These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright © 2011 by the National Electrical Manufacturers Association. Show Usage * DICOM Controlled Terminology Definitions: AcquisitionModality, Bundle/bun-1... Show 6 more, Bundle/bun-3, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example, ImagingStudy/imaStu-min and ImagingStudyTWPAS ( src )

This material contains content from LOINC. LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. Show Usage * LOINC: Bundle/bun-1, Bundle/bun-3... Show 34 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example, Composition/opd, CompositionOpdTWPAS, Condition/con-comorbidity, Condition/con-diagnosis, ConditionTWPAS, DNAChangeType, DiagnosticReport/diaRep-ima-loinc, DiagnosticReport/diaRep-min, DiagnosticReport/inline-2-diaRep-ima-loinc, DiagnosticReport/inline-diaRep-ima-loinc, DiagnosticReportImageTWPAS, DiagnosticReportTWPAS, GeneTestCode, ImagingReport, Observation/obs-blood-group, Observation/obs-diagnostic-min, Observation/obs-lab-cbc, Observation/obs-lab-min, Observation/obs-objective, Observation/obs-pat-nyha, Observation/obs-subjective, ObservationDiagnosticTWPAS, ObservationLaboratoryResultTWPAS, ObservationObjectiveTWPAS, ObservationPatientAssessmentTWPAS, ObservationSubjectiveTWPAS, PatAst, ReportType, Specimen/spe-min, SpecimenTWPAS and SpecimenType ( src )

This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html Show Usage * Adjudication Value Codes: Bundle/bun-response, Bundle/bun-self, Bundle/bun-uuid-example, ClaimResponse/claim-response-example and ClaimResponse/self-assessment-example * AllergyIntolerance Clinical Status Codes: AllergyIntolerance/all-min and Bundle/bun-imm * Claim Type Codes: Bundle/bun-1, Bundle/bun-3... Show 13 more, Bundle/bun-imm, Bundle/bun-response, Bundle/bun-self, Bundle/bun-uuid-example, Claim/cla-1, Claim/cla-3, Claim/cla-imm, ClaimImmTWPAS, ClaimResponse/claim-response-example, ClaimResponse/self-assessment-example, ClaimResponseSelfAssessmentTWPAS, ClaimResponseTWPAS and ClaimTWPAS * Condition Clinical Status Codes: Bundle/bun-imm, Condition/con-comorbidity, Condition/con-diagnosis and ConditionTWPAS * MedicationRequest Status Reason Codes: Bundle/bun-1, Bundle/bun-3... Show 4 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example and MedicationRequest/medReq-treat * Observation Category Codes: Bundle/bun-imm, Observation/obs-objective, Observation/obs-subjective, ObservationObjectiveTWPAS and ObservationSubjectiveTWPAS * Operation Outcome Codes: OperationOutcome/error-example * Organization type: Bundle/bun-1, Bundle/bun-3... Show 5 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example, 臺北市立聯合醫院 and 衛生福利部中央健康保險署 * identifierType: Bundle/bun-1, Bundle/bun-3... Show 8 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example, ClaimResponseRequestor, Patient/pat-min, Patient/pat-resident, Practitioner/pra-min and 臺北市立聯合醫院 * ActCode: Bundle/bun-1, Bundle/bun-3... Show 7 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example, Encounter/enc-min, Encounter/enc-opd, EncounterOpdTWPAS and EncounterTWPAS * GTSAbbreviation: Bundle/bun-1, Bundle/bun-imm... Show 6 more, Bundle/bun-self, Bundle/bun-uuid-example, MedicationRequest/medReq-apply, MedicationRequestApplyTWPAS, MedicationRequestTreatTWPAS and NHIMedicationFrequencyHL7 * ObservationInterpretation: Bundle/bun-1, Bundle/bun-3... Show 5 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example, Observation/obs-diagnostic-min and Observation/obs-lab-min * Orderable Drug Form: Bundle/bun-1, Bundle/bun-3... Show 4 more, Bundle/bun-imm, Bundle/bun-self, Bundle/bun-uuid-example and MedicationRequest/medReq-apply-2 ( src )

URBASON (R) SOUBILE FORTE 1000 FOR INJECTION ( src )

UROCIT(R)-K ( src )

VEKAIN TABLETS (R) ( src )

VISKALDIX TABLETS (R) ( src )

VOLTAREN (R) ENTERIC COATED TABLETS 25MG (DICLOFENAC) ( src )

YEEWAY SUSPENSION (ALUMINUM PHOSPHATE) (R) ( src )

在一些例子中，藥品請求可包括口服劑量或靜脈注射或肌肉注射劑量的選擇。例如：「昂丹司瓊（Ondansetron）8毫克口服或靜脈注射，每天兩次，治療噁心」或「康帕辛® （Compazine®）【丙氯拉嗪（prochlorperazine）】5-10毫克口服（PO）或25毫克經直腸給藥（PR）每天早、晚（飯後）1次（bid）需要時使用（prn）噁心或嘔吐」。在這些情況下，這兩個醫令的建立可歸為一組藥品醫令，基於病人在需要用藥時的情況決定使用哪種劑量和給藥途徑。 ( src )

臺灣健保事前審查實作指引(Taiwan NHI Prior Authorization Support Implementation Guide，TWPAS IG)採用HL7® FHIR® standard（Fast Healthcare Interoperability Resources）IG建置方法，在FHIR R4.0.1之標準基礎上，繼承TW Core IG V0.3.2 (2024-12-12)，進一步定義適用於「事前審查」資料需求的Resources（類似資料表）、其中的資料項目（意即欄位）、基數（意即0..1、0..*、1..1或1..*）及資料類型（文字、日期時間、代碼等）等。 ( src )

External References

Internal Images